Stimulative effect of transforming growth factor-β on collagen synthesis by human prostatic stromal cells in vitro

International Journal of Urology

Volumn 4, Issue 6, 1997, Pages 597-602

  Fukabori, Yoshitatsu ^a   Nakano, Katsuya ^a   Ohyama, Atsuko ^a   Yamanaka, Hidetoshi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

BPH; Collagen; Procollagen; Prostate stroma; TGF

Indexed keywords

COLLAGEN; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

AGED; ARTICLE; CASE REPORT; CELL CULTURE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME IMMUNOASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; RADIOIMMUNOASSAY; STROMA CELL;

EID: 0031435722     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1997.tb00316.x     Document Type: Article

References (29)

1. Ishigooka M, Hayami S, Hashimoto T, Suzuki Y, Katoh T, Nakada T. Relative and total volume of histological components in benign prostatic hyperplasia: relationships between histological components and clinical findings. Prostate 1996;29:77-82.
2. Davis BH. Transforming growth factor beta responsiveness is modulated by the extracellular collagen matrix during hepatic ito cell culture. J Cell Physiol 1988;136: 547-553.
3. Creely JJ, DiMari SJ, Howe AM, Haralson MA. Effects of transforming growth factor-beta on collagen synthesis by normal rat kidney epithelial cells. Am J Pathol 1992;140:45-55.
4. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991;11:1223-1230.
5. Mori H, Maki M, Oishi K, Jaye M, Igarashi K, Yoshida O, Hatanaka M. Increased expression of genes for basic fibroblast growth factor and transforming growth factor type beta 2 in human benign prostatic hyperplasia. Prostate 1990;16:71-80.
6. Kyprianou N, Isaacs JT. Expression of transforming growth factor-beta in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 1989;3:1515-1522.
7. Muntzing J. Androgen and collagen as growth regulators of the rat ventral prostate. Prostate 1980;1:71-78.
8. Kan M, Yamane I. In vitro proliferation and life span of human diploid fibroblasts in serum-free BSA-containing medium. J Cell Physiol 1982;111:155-162.
9. Ignotz RA, Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-4345.
10. Ignotz RA, Massague J. Cell adhesion protein receptors as targets for transforming growth factor-beta action. Cell 1987;51:189-197.
11. Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell 1988; 52:405-414.
12. Ritzenthaler JD, Goldstein RH, Fine A, Lichtler A, Rowe DW, Smith BD. Transforming-growth-factor-beta activation elements in the distal promoter regions of the rat alpha 1 type I collagen gene. Biochem J 1991;280: 157-162.
13. Ritzenthaler JD, Goldstein RH, Fine A, Smith BD. Regulation of the alpha 1(I) collagen promoter via a transforming growth factor-beta activation element. J Biol Chem 1993;268:13625-13631.
14. Inagaki Y, Truter S, Ramirez F. Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 1994;269:14828-14834.
15. Chung KY, Agarwal A, Uitto J, Mauviel A. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Chem 1996; 271:3272-3278.
16. Czaja MJ, Weiner FR, Flanders KC, Giambrone MA, Wind R, Biempica L, Zern MA. In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J Cell Biol 1989;108:2477-2482.
17. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 1991;324:933-940.
18. Raghu G, Masta S, Meyers D, Narayanan AS. Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-beta. Am Rev Respir Dis 1989;140:95-100.
19. Davidson JM, Zoia O, Liu JM. Modulation of transforming growth factor-beta 1 stimulated elastin and collagen production and proliferation in porcine vascular smooth muscle cells and skin fibroblasts by basic fibroblast growth factor, transforming growth factor-alpha, and insulin-like growth factor-I. J Cell Physiol 1993;155:149-156.
20. Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990;63:515-524.
21. Cheifetz S, Hernandez H, Laiho M, ten-Dijke P, Iwata KK, Massague J. Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. J Biol Chem 1990;265:20533-20538.
22. Boyd FT, Cheifetz S, Andres J, Laiho M, Massague J. Transforming growth factor-beta receptors and binding proteoglycans. J Cell Sci 1990;13(suppl):131-138.
23. Rohde H, Vargas L, Hahn E, Kalbfleisch H, Bruguera M, Timpl R. Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 1979;9:451-459.
24. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Docherty AJ, Angel P, Heath JK. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6:1899-1904.
25. Glynne JE, Harper ME, Goddard L, Eaton CL, Matthews PN, Griffiths K. Transforming growth factor beta 1 expression in benign and malignant prostatic tumors. Prostate 1994;25:210-218.
26. Muir GH, Butta A, Shearer RJ, Fisher C, Dearnaley DP, Flanders KC, Sporn MB, Colletta AA. Induction of transforming growth factor beta in hormonally treated human prostatic cancer. Br J Cancer 1994;69:130-134.
27. Timme TL, Truong LD, Slawin KM, Kadmon D, Park SH, Thompson TC. Mesenchymal-epithelial interactions and transforming growth factor-beta 1 expression during normal and abnormal prostatic growth. Microsc Res Tech 1995;30:333-341.
28. Fukabori Y. Determination of 5 alpha-androstane-3 alpha, 17 beta-diol in human serum by GC-SIM and influence of age-associated change. Folia Endocrinol Jpn (Nippon Naibunpi Gakkai Zasshi) 1988;64:340-353 (in Japanese).
29. Suzuki K, Inaba S, Takeuchi H, Takezawa Y, Fukabori Y, Suzuki T, Imai K, Yamanaka H, Honma S. Endocrine environment of benign prostatic hyperplasia - relationships of sex steroid hormone levels with age and the size of the prostate. Jpn J Urol (Nippon Hinyokika Gakkai Zasshi) 1992;83:664-671 (in Japanese).